Background: Topical retinoids are used to treat the visible signs of photoaging.
| INTRODUCTION
Changes to skin are among the most visible signs of aging. Photodamage or extrinsic aging, resulting from sun exposure and ultraviolet radiation, accelerates the natural changes of aging and is a primary cause of premature aging of the skin. Intrinsic or chronological aging markedly impacts skin barrier function and is multifactorial. 1 Reduction in the number of melanocytes in the skin, as well as an increase in the size of melanocytes, results in thinner, paler, and more translucentlooking skin. Sebaceous glands produce less oil, causing the skin to become drier. Reductions in collagen type I manifest as fine lines, wrinkles, and skin laxity. Changes in connective tissue cause elastosis, reducing skin strength and elasticity, facilitating development of irregular elastin structure. Collagen and elastin provide structural support to skin pores; however, the loss of both collagen and elastin enable pores to stretch and sag around their edges, making them appear larger. Notably, the rate of cell turnover and shedding of dead skin cells naturally slows with age; dead cells accumulate on the outer surface of the skin, giving the complexion a dull, sallow look. 2 Visible effects of photodamage may manifest as fine lines and wrinkles, erythema, pigmentary and skin tone changes, a larger appearance in pore size, and skin sagging and crepiness.
Topical agents are often utilized to promote exfoliation and facilitate cell turnover. This removes the top layer of dead skin that dulls the skin's appearance and enhances cell renewal rate, improving the appearance of the skin and the visible signs of photoaging. Both retinoid-containing derivatives (prescription and nonprescription) and alpha hydroxy acids (AHAs) are established treatments which have been shown to effectively improve visible skin changes associated with aging.
2
Retinoids and AHAs are often referred to as "gold standard" ingredients due to their ability to rejuvenate the skin by influencing the rate of cell turnover and exfoliation. AHAs (especially lactic and glycolic acid) impart benefits to the skin by both fostering skin moisturization and promoting skin exfoliation. 2, 3 AHAs exfoliate the surface of the skin, facilitating skin turnover and renewal of the stratum corneum, improving skin texture, fine lines and wrinkles, and pigmentation. 4 At lower doses, AHAs modulate the surface of the skin and epidermal changes; at higher concentrations they influence the epidermal and dermal layers. 4, 5 Additionally, lactic acid has a specific glycoprotein-binding site on the fibroblast that induces moisture retention in the dermis and epidermis. Increasing skin moisture retention increases epidermal and dermal volume, thus reducing fine lines and wrinkles and increasing brightness of the skin. 2 As the smallest AHA molecule, glycolic acid penetrates the skin more readily than other AHA molecules and has the greatest bioavailability. Glycolic acid also has both anti-inflammatory and antioxidant effects, and is safe to use with all Fitzpatrick skin types. 3, 6 Retinoids increase cellular mitosis, stimulate collagen production to thicken and repair the epidermis, normalize melanocyte function, and regulate skin cell metabolism and cellular turnover, thereby improving pigmentation, skin texture and roughness, and fine lines and wrinkles. 2, [7] [8] [9] [10] Tretinoin is a prescription strength retinoid approved by the US Food and Drug Administration (FDA) for acne and for the mitigation of fine facial wrinkles, mottled hyperpigmentation, and tactile roughness of facial skin. Prescription strength tretinoin affords the most potent retinoid effects, but often results in limited utility and decreased adherence due to irritation reactions (ie, burning, scaling, and dermatitis). 11 Although early studies showed no statistically significant difference (clinically or histologically) in efficacy between lower (0.025%) and higher (0.1%) strength tretinoin on photodamaged skin, there are significantly greater adverse effects associated with the higher strength formulation. 12 While the "no pain, no gain" adage may be more acceptable to patients when associated with chemical peels or device-based procedures in an attempt to improve photodamaged skin, side effects from topical agents can result in poor compliance and/or treatment discontinuation.
Tran and colleagues demonstrated that the combination of an AHA (glycolic acid) with a retinoid regimen facilitated better bioavailability and greater delivery of the retinoid while reducing or preventing tolerability issues. 13 In an effort to mitigate the tension that currently exists between efficacy and tolerability, a bioengineered, nonprescription retinoid or retinol product within the prior 4 weeks); pregnancy or lactating during the study period; and must be able and willing to comply with the protocol requirements and sign a written informed consent.
| Methods
The study was conducted by a board-certified dermatologist under Independent Review Board (IRB; Chesapeake IRB, Columbia, MD, USA) approval in conjunction with current Good Clinical Practices (cGCP) guidelines. The initial screening visit, which may have been combined with the baseline visit, included obtaining informed consent, medical history, demographics, and concomitant medication history;
along with inclusion/exclusion criteria review. Enrolled subjects were instructed to apply study products to clean skin, once daily in the evening for 12 weeks. Subjects were instructed to use sunscreen in the morning and a moisturizer, followed by use of their routine makeup products (if applicable). In addition to study products, cleanser, moisturizer, and a sunscreen were provided to ensure consistency of treatment regimen throughout the study period. AHA-Ret was provided by the sponsor in individual containers containing only lot and batch numbers. Comparator product(s) were provided in commercial packaging to keep from contaminants and for stability purposes.
In a split-face design, subjects were instructed to apply AHA-Ret 
| Study endpoints and assessments

| Statistical analysis
An independent statistician analyzed data using nonparametric
Mann-Whitney and Wilcoxon signed-rank tests to determine statistical significance for respective parameters relative to baseline, across all three groups and examined a noninferiority hypothesis.
3 | STUDY RESULTS
| Study population
Forty-seven subjects with an average age of 55 years and Fitzpatrick skin type II completed the study. One subject was lost to follow-up. 
Fine lines/wrinkles
There was a statistically significant reduction in average severity scores from baseline in Fine Lines/Wrinkles for AHA-Ret at all time points: 14.3% at 4 weeks, 23.8% at 8 weeks, and 33.3% at 12 weeks (P=.0001, all) ( Figure 3A ). Retinol did not achieve statistically significant differences in Fine Lines/Wrinkles at 4 weeks, while tretinoin achieved statistical significance through week 12 (P=.02, P=.002, and P=.0001, respectively).
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Dyschromia
There was a statistically significant reduction in average severity 
Skin tone degradation
There was a statistically significant reduction in average severity scores 
AHA-Ret demonstrated statistically significant increases in Global
Improvement from baseline at 4, 8, and 12 weeks (P<.0001, all).
There were no statistical differences between the groups in average Global Improvement at 12 weeks.
In a noninferiority test with 10% margins, AHA-Ret was noninferior to retinol in each category over 12 weeks. AHA-Ret was noninferior to tretinoin in each category at 4 and 8 weeks, and in Fine Lines/Wrinkles, Erythema, Dyschromia, and Skin Tone Degradation at 12 weeks.
| Tolerability
There were 20 reports of adverse events (AEs) in nine subjects; the majority of events were mild and transient and included blemishes, dryness, flakiness, redness, tingling, stinging, burning, and solar sensitivity. There were seven cases of retinoid dermatitis among subjects in the retinol group, all deemed "probably treatment-related". Six of these subjects switched to AHA-Ret with no further adverse events, and one subject required a 2-week rest period from retinol. Two "possibly treatment-related" AEs involved postinflammatory responses subsequent to eyebrow waxing; both were associated with 1.0% retinol. There were no product discontinuations among subjects in either the AHA-Ret or tretinoin groups. demonstrated between products based on subject self-assessments.
| DISCUSSION
The cumulative effects of unprotected exposure to the sun and ultraviolet radiation are well documented. Clinical studies have concluded that half of an individual's exposure to sun and UV radiation occurs prior to age 18; 14 however, the visible consequences of photodamage may not be apparent for decades afterward. While exposure before age 18 is significant, ongoing environmental exposure also contributes to cumulative photoaging from lower intensity, chronic exposure to the UVA spectrum. Recent knowledge suggests that near infrared A and visible light also contribute to premature photoaging. Environmental damage from ozone, airborne particulates, and other types of pollution likely influence the development of wrinkles and pigment dyschromia. 15 The desire to ameliorate the visible effects of photoaged skin, particularly among the large basis, although common practice for retinol and tretinoin "beginners"
involves application 2-3 times/wk.
| Study conclusions
Treatment with a double-conjugate retinoid cream achieved early, progressive improvements in the appearance of Fine Lines/Wrinkles, Dyschromia, Erythema, Skin Tone, Pore Size, and Global Improvement over 12 weeks, and significant improvements in skin Hydration. AHA-Ret induced significantly less Erythema vs 1.0% retinol at 8 and 12 weeks, and was more tolerable than 1.0% retinol and 0.025% tretinoin. Treatment with AHA-Ret, a double-conjugated retinoid cream, represents a new advancement in skin rejuvenation, delivering optimal retinoid efficacy with minimal irritation in individuals with photodamaged skin.
